Bladder Oncology/Testis/Transplantation/TraumaV8-05 ROBOTIC KIDNEY TRANSPLANTATION: OUR FIRST CASE

You have accessJournal of UrologyBladder Oncology/Testis/Transplantation/Trauma1 Apr 2016V8-05 ROBOTIC KIDNEY TRANSPLANTATION: OUR FIRST CASE Alberto Breda, Lluís Gausa, Angelo Territo, Ivan Schwartzmann, Oscar Rodríguez, Jorge Caffaratti, Javier Ponce de León, and Humberto Villavicencio Alberto BredaAlberto Breda More articles by this author , Lluís GausaLluís Gausa More articles by this author , Angelo TerritoAngelo Territo More articles by this author , Ivan SchwartzmannIvan Schwartzmann More articles by this author , Oscar RodríguezOscar Rodríguez More articles by this author , Jorge CaffarattiJorge Caffaratti More articles by this author , Javier Ponce de LeónJavier Ponce de León More articles by this author , and Humberto VillavicencioHumberto Villavicencio More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.748AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Kidney transplantation is the preferred treatment for patients with end-stage renal disease. In order to reduce the morbidity of the open surgery, a robotic assisted approach has been recently introduced. According to the literature, the robotic surgery allows the performance of kidney transplantation under optimal operative conditions while maintaining the safety and the functional results of the open approach. Herein, we report our first case of Robotic Assisted Kidney Transplantation (RAKT). METHODS We present the case of a mother donating to her daughter affected by end stage renal disease (ESRD) due to Alport Disease (creatinine: 353 Umol/l; GFR: 13 ml/min per 1.73 m2). RESULTS A RAKT was successfully performed. Surgical time was 120 min with 53 min for vascular suture. The estimated blood loss was < 50 cc. The kidney started to produce urine intra-operatively with a rate of 250 cc/hour, which remained constant over the next hours. During the first postoperative day the patient was ambulating and started oral intake. Pain was minimal, and no analgesia was required after 48 h. Serum creatinine improved progressively to 89 umol/L on postoperative day three. No surgical complications were recorded and the patient was sent home on postoperative day 5. CONCLUSIONS We present our first experience in RAKT from living related donors. We believe that the potential advantages of RAKT are related to the quality of the vascular anastomosis, the possible lower complication rate and the shorter recovery of the recipients. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e772 Advertisement Copyright & Permissions© 2016MetricsAuthor Information Alberto Breda More articles by this author Lluís Gausa More articles by this author Angelo Territo More articles by this author Ivan Schwartzmann More articles by this author Oscar Rodríguez More articles by this author Jorge Caffaratti More articles by this author Javier Ponce de León More articles by this author Humberto Villavicencio More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...